Vivo Bio Tech

Market Cap: Micro Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE380K01017
NSEID:
BSEID: 511509
View on BSE

INR

25.15

-0.14 (-0.55%)

BSENSE

Mar 25

BSE+NSE Vol: 25.62 k

Access older stock analysis version

Company CV

About Vivo Bio Tech Ltd.

Vivo Bio Tech Ltd.

Micro Cap

Pharmaceuticals & Biotechnology

Vivo Bio Tech Limited, established in February, 1987 is a full service CRO offering drug development & discovery services to pharmaceutical & biotech companies world-wide in accordance with OECD, AAALAC & IND guidelines. The company offers services in the areas of In vitro, In vivo, toxicity studies, pharmacological investigations, pharmacokinetics & toxicokinetic studies etc. Their experienced & talented scientists offer advice on defining drug development paths tailored to specific molecules.

Company Coordinates

Company Details

Survey #349/A Pregnapur Vlge , Gajel Telangana : 502311

Tel:

http://www.vivobio.com

investors@vivobio.com

Registrar Details

Aarthi Consultants Pvt Ltd, 1-2-285 , Domalaguda, Hyderabad

Capital Structure

Present Equity Capital

INR 14.90 Cr

Number of Shares

1.49 Cr

Face Value

INR 10.0

Date

Number
of Shares(Cr)

Equity
Capital (Rs Cr)

Shares Added

Face Value (Rs)

Reason

03-Jan-2023

1.49

14.90

27000

Issued under ESOP Scheme

05-May-2022

1.49

14.88

613000

Conversion of Warrants

01-Feb-2022

1.43

14.26

59000

Issued under ESOP Scheme

30-May-2021

1.42

14.20

210000

Conversion of Warrants

05-May-2021

1.4

13.99

130000

Issued under ESOP Scheme

22-Apr-2021

1.39

13.86

230000

Conversion of Warrants

15-Apr-2021

1.36

13.63

215000

Conversion of Warrants

30-Mar-2021

1.34

13.42

150000

Preferential issue/warr.conversion

25-Mar-2021

1.33

13.27

382000

Conversion of Warrants

22-Oct-2019

1.29

12.89

137000

Issued under ESOP Scheme

Shareholding

Shareholding Snapshot

Shareholding Compare (%holding)

Majority shareholders

Non Institution

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

Cryptologic Systems Private Limited (6.09%)

Highest Public shareholder

Antique Infotech Private Limited (11.76%)

Individual Investors Holdings

32.7%

Board of Directors

Period

Management

Designation

Remuneration

Kalyan Ram Mangipudi

Whole-time Director

8.61 lacs

Alangudi Sankaranarayanan

Whole-time Director

3.47 lacs

K Sunder

Chairman & Independent Directo

1.8 lacs

Hariharan Ravindran

Independent Director

1.15 lacs

Kunda Kalpana

Independent Director

1.8 lacs

Karopadi Shivanand Nayak

Director

80.0 k

K Sri Kalyan

Whole Time Director & CFO

3.7 lacs

Shyam Sunder Tipparaju

Additional Director

Raw Materials

Raw Materials Dashboard

Raw Materials

Amount(Rs Cr)

% of RM Cost

Purchases

4.8077

Purchases

Finished Goods

Finished Goods Dashboard

Finished Goods

Amount(Rs Cr)

% of Sales Turnover

Income from Pharmaceuticals Services

47.00

100.00%

Income from Pharmaceuticals Services

Stock DNA

Revenue and Profits:

Net Sales:

14 Cr

(Quarterly Results - Dec 2025)

Net Profit:

1 Cr

Industry

Pharmaceuticals & Biotechnology

Market cap

INR 57 Cr (Micro Cap)

P/E

12.00

Industry P/E

Dividend Yield

0.00%

Debt Equity

0.58

Return on Equity

4.30%

Price to Book

0.58